CD44 and cancer: Since studies on cancer and renal ischemia mentioned the function of HA-CD44 in nanoparticle-based strategies for satisfactory efficacy (Awadalla et al. 2021; Chen et al. 2021), HA-loaded exosomes or nanoparticles may bring out the promise for the application in MI treatment.